Effects of Urban Afforestation Activity on Mental Health

Sponsor
Universidad de Granada (Other)
Overall Status
Completed
CT.gov ID
NCT05362552
Collaborator
(none)
152
1
1
11
420.6

Study Details

Study Description

Brief Summary

This single-group pretest-posttest clinical trial aims to evaluate the effects of a single-session afforestation activity on affect and vitality levels in a sample of young adults.

Condition or Disease Intervention/Treatment Phase
  • Other: Urban Afforestation Program
N/A

Detailed Description

The participants will perform an afforestation activity for a single session of 90 minutes. The therapists will direct the participants' attention to the visual, auditory, olfactory, and tactile features of the surrounding environment.

Study Design

Study Type:
Interventional
Actual Enrollment :
152 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Positive Effects of an Urban Afforestation Activity on the Mental Health of Adults
Actual Study Start Date :
May 9, 2022
Actual Primary Completion Date :
May 20, 2022
Actual Study Completion Date :
May 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Urban Afforestation Group

Participants will perform an afforestation activity with a duration of 90 minutes.

Other: Urban Afforestation Program
An afforestation program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.
Other Names:
  • Nature-based activity
  • Afforestation activity
  • Outcome Measures

    Primary Outcome Measures

    1. Affect [Change from baseline affect after 90 minutes.]

      The Spanish adaptation of the Positive and Negative Affect Schedule will be utilised. Participants rate how they feel at the present moment on a five-point Likert scale, where "not at all or very slightly" is scored as 1 and "a lot" as 5. Scores of two 10-item subscales will be analysed separately in the analysis, labelled either as Positive Affect or Negative Affect. Higher scores in the Positive Affect subscale represent higher levels of positive affect and lower scores in the Negative Affect subscale represent lower levels of negative affect.

    2. Subjective Vitality [Change from baseline subjective vitality after 90 minutes.]

      The 6-item Spanish adaptation of the Subjective Vitality Scale will be utilised. Participants will transmit their levels of energy and aliveness at the present moment by rating the items on a seven-point Likert scale where 1 stands for "Not true at all" and 7 "Very true". The scores for each item will be summed up for statistical analyses. Higher scores indicate higher levels of energy and aliveness feeling.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Adults between 18 and 65 years.

    • Any sex and gender.

    Exclusion Criteria:
    • Intake of any psychotropic medication.

    • Other severe or medically unstable diseases that may interfere with participation.

    • Severe cognitive impairment (Mini-Mental State Examination score < 17 out of 30 points).

    • Severe mental disorders in the acute phase or symptomatic phase.

    • Severe intellectual disability.

    • Behavioural alterations as this may interfere with their participation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Granada, Faculty of Health Sciences Granada Spain 18071

    Sponsors and Collaborators

    • Universidad de Granada

    Investigators

    • Principal Investigator: José Manuel PÉREZ-MÁRMOL, PhD, Associate Professor

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    José Manuel Pérez Mármol, Associate Professor, Universidad de Granada
    ClinicalTrials.gov Identifier:
    NCT05362552
    Other Study ID Numbers:
    • AfforestAffect
    First Posted:
    May 5, 2022
    Last Update Posted:
    May 23, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by José Manuel Pérez Mármol, Associate Professor, Universidad de Granada

    Study Results

    No Results Posted as of May 23, 2022